Glaucoma Surgery Devices Market To Reach $4.3 Billion by 2035

Glaucoma surgery devices market is projected to grow from $2.1 billion in 2025 to $4.3 billion by 2035, reflecting a compound annual growth rate (CAGR) of 7.4% over the forecast period of 2026–2035. A key macroeconomic driver underpinning this growth is the escalating global burden of glaucoma. According to the Glaucoma Research Foundation, glaucoma has been identified as one of the leading causes of blindness worldwide, with approximately 80 million people currently affected by the disease. A particularly concerning aspect is that nearly half of all patients remain undiagnosed, largely due to the condition's asymptomatic or "silent" progression in its early stages. This diagnostic gap underscores the urgent need for improved early detection mechanisms and timely therapeutic interventions. Although no definitive cure currently exists for glaucoma, advanced treatment modalities - including surgical procedures supported by specialized devices - have demonstrated significant efficacy in slowing disease progression and preserving vision. As awareness of the condition continues to rise alongside an aging global population, the demand for glaucoma surgery devices is expected to witness sustained and robust growth throughout the forecast period.

Browse the full report description of “Glaucoma Surgery Devices Market Size, Share & Trends Analysis Report By Product Type (Minimally Invasive Glaucoma Surgery (MIGS) Devices, Glaucoma Drainage Devices (GDD), Laser Surgery Devices, Traditional Surgical Devices), By Surgical Method (Minimally Invasive Glaucoma Surgery (MIGS), Laser-based Surgery, Conventional Incisional Surgery), By End User (Hospitals, Ophthalmic Clinics, Ambulatory Surgical Centers (ASCs)), and Forecast Period (2026–2035)” at https://www.omrglobal.com/industry-reports/glaucoma-surgery-devices-market

Innovation Leaders Transforming the Glaucoma Surgery Devices Market

The glaucoma surgery devices market is witnessing strong momentum, driven by leading players such as Johnson & Johnson Vision, AbbVie, Alcon, Bausch + Lomb, Santen Pharmaceutical, and Carl Zeiss Meditec. Increasing global prevalence of glaucoma is pushing the demand for effective surgical interventions, especially in aging populations. At the same time, the rapid shift toward minimally invasive glaucoma surgery (MIGS) is improving patient outcomes and reducing recovery times. These advancements, combined with continuous product innovation and expanding access to ophthalmic care, are significantly accelerating the adoption of advanced glaucoma surgical solutions worldwide.

• In January 2026, Glaukos Corporation announced that the US FDA approved a supplemental labelling for its iDose TR travoprost intracameral implant, allowing physicians to re?administer the implant using a repeat treatment protocol. The approval reflects accumulated clinical evidence supporting the safety and tolerability of repeat use for managing intraocular pressure in glaucoma patients. This regulatory milestone underscores the growing adoption of innovative implantable solutions in the glaucoma surgery devices market.

• In June 2024, Santen expanded the PRESERFLO MicroShunt availability in Europe.

Market Coverage

• The market number available for – 2025–2035
• Base year- 2025
• Forecast period- 2026–2035
• Segment Covered-
• By Product Type
• By Surgical Method
• By End User
• Regions Covered-
• North America
• Europe
• Asia-Pacific
• Rest of the World
• Competitive Landscape: Johnson & Johnson Vision, AbbVie, Alcon, Bausch + Lomb, Santen Pharmaceutical, and Carl Zeiss Meditec, among others

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Glaucoma Surgery Devices Market Report Segment

By Product Type

• Minimally Invasive Glaucoma Surgery (MIGS) Devices
• Glaucoma Drainage Devices (GDD)
• Laser Surgery Devices
• Traditional Surgical Devices

By Surgical Method

• Minimally Invasive Glaucoma Surgery (MIGS)
• Laser-based Surgery
• Conventional Incisional Surgery

By End User

• Hospitals
• Ophthalmic Clinics
• Ambulatory Surgical Centers (ASCs)

Global Glaucoma Surgery Devices Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/glaucoma-surgery-devices-market